Rifaximin
Rifaximin
Definition
An orally administered, semi-synthetic, nonsystemic antibiotic derived from rifamycin SV with antibacterial activity. Rifaximin binds to the beta-subunit of bacterial DNA-dependent RNA polymerase, inhibiting bacterial RNA synthesis and bacterial cell growth. As rifaximin is not well absorbed, its antibacterial activity is largely localized to the gastrointestinal tract.
Also known as RIFAXIMIN, Xifaxan — per NCIT
Also identified as
- ATC A07AA11 per RXNORM
- ATC D06AX11 per RXNORM
- NCIT NCIT:C61926 per NCIT
- SCTID 412553001 per RXNORM
- SCTID 412554007 per RXNORM
- UNII L36O5T016N per RXNORM
Indications
| Disease | Relation | Source |
|---|---|---|
| Hepatic encephalopathy | may prevent | MEDRT · Public domain (U.S. Government work) |
| Diarrheal disease | may treat | MEDRT · Public domain (U.S. Government work) |
| Irritable bowel syndrome | may treat | MEDRT · Public domain (U.S. Government work) |
Organ Effects
| Organ | Side effect / interaction | Source |
|---|---|---|
| Alimentary part of gastrointestinal system | may treat a disease of this organ | DERIVED · CC BY 4.0 |
| Intestine | may treat a disease of this organ | DERIVED · CC BY 4.0 |
2 entries above are marked DERIVED: Atlas Médico inferred them by combining two sourced claims, and no source asserts these links directly. Treat them as a navigation aid, not as a clinical statement.